Latest News about COVID/19 Coronavirus
Recent news which mentions COVID/19 Coronavirus
   Pfizer Commits 10M Courses Of COVID-19 Oral Antiviral To Developing Countries: Reuters
   
  March 03, 2022
  Tickers 
   PFE
  
  
  From Benzinga
 From Benzinga
 
   Johnson & Johnson's COVID-19 Vaccine Less Effective Against Hospitalization, French Study Shows
   
  
  
  March 03, 2022
  From Benzinga
 
   Pfizer/BioNTech's COVID-19 Vaccine Mere 12% Effective In Kids 5-11 Years, New York Study Shows
   
  
  
  March 01, 2022
  From Benzinga
 
   RedHill Biopharma's Upamostat Shows 100% Efficacy In Non-Hospitalized COVID-19 Patients
   
  March 01, 2022
  Tickers 
   RDHL
  
  
  From Benzinga
 
   Cardiol Therapeutics To Include Vaccinated Participants In Cannabidiol COVID-19 Trial
   
  March 01, 2022
  Tickers 
   CRDL
  
  
  From Benzinga
 From Benzinga
 
   Longer Waiting Period Between mRNA COVID-19 Doses May Cut Heart Inflammation Risk, CDC Suggests
   
  
  
  February 25, 2022
  From Benzinga
 
   Canada Approves First Plant-Based COVID-19 Vaccine
   
  
  
  February 25, 2022
  From Benzinga
 
   Chimerix's CMX521 Antiviral Program Shows Potential Against COVID-19 In Preclinical Studies
   
  February 24, 2022
  Tickers 
   CMRX
  
  
  From Benzinga
 From Benzinga
 From Benzinga
 From Benzinga
 
   Adagio Lays Out Development Plans For COVID-19-Focused ADG20 Program
   
  February 22, 2022
  Tickers 
   ADGI
  
  
  From Benzinga
 
   Valneva Secures £20M From Scottish Enterprise For Vaccine Development
   
  February 22, 2022
  Tickers 
   VALN
  
  
  From Benzinga
 
   FDA Lifts Clinical Hold On Ocugen's COVID-19 Vaccine Study In US
   
  February 22, 2022
  Tickers 
   OCGN
  
  
  From Benzinga
 
   See Why Did FDA Update Merck's COVID-19 Pill Emergency Use Authorization
   
  
  
  February 18, 2022
  From Benzinga
 From Benzinga
 
   Moderna Says COVID-19 Booster To Be Ready By August, But Dicey If Omicron-Specific Needed: Reuters
   
  February 17, 2022
  Tickers 
   MRNA
  
  
  From Benzinga
 
   South Africa Authorizes Merck's COVID-19 Antiviral Pill, But Government Not Buying: Reuters
   
  
  
  February 17, 2022
  From Benzinga
 
   Regencell Bioscience's COVID-19 Candidate Shows Encouraging Action On Mild To Moderate Symptoms
   
  February 17, 2022
  Tickers 
   RGC
  
  
  From Benzinga
 
   Short Shelf Life Of AstraZeneca's COVID-19 Shot Entangles Vaccine Rollout In Poorer Nations: Reuters
   
  
  
  February 16, 2022
  From Benzinga
 
   Enanta Pharma Commences Dosing In Phase 1 COVID-19 Trial
   
  February 16, 2022
  Tickers 
   ENTA
  
  
  From Benzinga
 
   Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
  
  
 Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
  © 2025 FinancialContent. All rights reserved.
 
